Table 3.
The number of dogs grouped according to serum symmetric dimethylarginine (sSDMA) (≤ 14, 15–19, ≥ 20 μg/dl) [14] at T1, T2, and T3
| Parameters * | Time points | Comparison‡ | |||||||
|---|---|---|---|---|---|---|---|---|---|
| T1 | P† | T2 | P† | T3 | P† | T2 vs T1 | T3 vs T1 | ||
| sSDMA | 0.03 | 0.99 | 0.48 | ||||||
| Group T | ≤ 14 μg/dl | 5 (41.67) | 9 (75.00) | 5 (41.67) | 0.17 | 0.26 | |||
| 15–19 μg/dl | 5 (41.67) | 1 (8.33) | 6 (50.00) | ||||||
| ≥ 20 μg/dl | 2 (16.67) | 2 (16.67) | 1 (8.33) | ||||||
| Group C | ≤ 14 μg/dl | 9 (90.00) | 8 (80.00) | 7 (70.00) | 0.32 | 0.16 | |||
| 15–19 μg/dl | 0 (0.00) | 1 (10.00) | 2 (20.00) | ||||||
| ≥ 20 μg/dl | 1 (10.00) | 1 (10.00) | 1 (10.00) | ||||||
* As frequency and percentage (%)
†Fisher’s test
‡ McNemar–Bowker test